Analysis of polypharmacy in older adults pre- and post-COVID-19
Each pre-COVID diagnoses and medication were associated with quantifiable increase post-COVID, with higher risk with advanced age, Black race and female gender. Single health system data may inhibit generalizability of our findings. Clinicians should be vigilant and prepared to manage post-COVID-19 polypharmacy.
Authors
- Demetra Antimisiaris (ORCID: https://orcid.org/0000-0003-1810-1961)
- Shaminul H. Shakib (ORCID: https://orcid.org/0009-0001-8268-5984)
Institutions
- University of Louisville (US)
- Sam Houston State University (US)
- University of Louisville Hospital (US)
Publication Details
- Journal
- Expert Review of Clinical Pharmacology
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1080/17512433.2025.2596347
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00